Kent Mouw
@mouwlab
Radiation oncology physician-scientist
@danafarber @brighamwomens
Assistant Professor
@harvardmed
#DNArepair #bladdercancer #prostatecancer
ID:958804413698793472
http://www.mouwlab.dana-farber.org 31-01-2018 20:49:20
297 Tweets
1,0K Followers
578 Following
Follow People
Excellent talk on PPARG/MAPK cross-talk in bladder cancer by Raie Bekele from the Kent Mouw at Brigham and Women's Hospital Department of Urology Grand Rounds this AM. My worlds colliding! Thanks Raie!
IBCN 2024 REMINDER: The deadline for abstract submission is rapidly approaching! Abstracts must be submitted by May 31st. ibcnweb.com/abstracts/
Roland Seiler-Blarer
Peter Black
Tilman Todenhöfer
Kent Mouw
Lars Dyrskjøt
@JeffreyD_UNC
Brewing urologic oncologists Christopher J. Magnani, MD MS and Jason Qian presenting at #EAU24 work done in the lab in close collaboration with Kent Mouw. Growing computational urology community Brigham and Women's Hospital Department of Urology #residents Adam Kibel Dana-Farber
Kent Mouw Laura Bukavina European Urology Neil Desai joaquim bellmunt Very nice work Kent and team! Kent Mouw Hopeful we’ll see the same remarkable benefits of ADC combinations in early stage trials Bladder Cancer Advocacy Network Shilpa Gupta Timothy Chan Chris Weight Nima Almassi ROBIN Gen-Rad Center
clinicaltrials.gov/study/NCT05833…
🚨Just out in European Urology🚨
Kent Mouw et al. modeled the additive value of ADCs 💉(SG or EV) with XRT ☢️⚡️for #bladdercancer
joaquim bellmunt Filipe LF Carvalho Will Anderson
@danafarber @brighamwomens Brigham and Women’s Radiation Oncology European Association of Urology (EAU) Bladder Cancer Advocacy Network Brigham and Women's Hospital Department of Urology Dana-Farber_GU
Link:…
Thanks Laura Bukavina! Very much appreciate the rigorous and efficient review process at European Urology and very excited to see our work in print. Looking forward to clinical trials in this space Omar Mian Neil Desai joaquim bellmunt
⚡️Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer
#BladderCancer joaquim bellmunt
Filipe LF Carvalho
Will Anderson Kent Mouw European Urology
europeanurology.com/article/S0302-…
Join us September 19-21, 2024 in Bern, Switzerland for the IBCN Annual Meeting. See below for an amazing lineup of topics and speakers!!! Abstract deadline May 31st!! Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt
Happy to share this latest work from our lab online now European Urology!
authors.elsevier.com/a/1iov514kplyy…
We report exciting activity of EV and SG in combination with radiation in preclinical bladder cancer models.
Led by Yuzhen Zhou with help from Filipe LF Carvalho joaquim bellmunt et al.
Congrats Filipe - so well-deserved! Very excited to continue working together to unravel therapy resistance in bladder cancer! Dana-Farber Brigham and Women's Hospital Department of Urology Dana-Farber_GU @BladdeCancerUS
We are happy to announce the results of the 2024 Match and to introduce you to our HROP class of 2029!! #Match2024 #MatchDay #radonc #MedTwitter
Thanks! Really enjoyed your talk as well Sangeeta Goswami, MD,PhD! It was a fun and informative session Amer. Urol. Assn. Johns Hopkins Greenberg Bladder Cancer Institute David McConkey Madhuri Koti
Join the 2024 Walk to End Bladder Cancer! Together, we'll raise awareness and funds for over 725,000 people fighting bladder cancer. Sign up, earn prizes, and make an impact. #WalkToEndBladderCancer Click here to learn more and register: secure2.convio.net/bcani/site/SPa…
While many of us are familiar with mismatch repair deficiency and homologous recombination deficiency, one DNA repair pathway that does not get as much attention is nucleotide excision repair (NER) (1/5) #AMPtutorials
We are excited to announce that meeting registration and abstract submission for the 2024 IBCN Annual Meeting in Bern, Switzerland is now OPEN! Please visit ibcnweb.com for all the details. #IBCN2024 Peter Black Tilman Todenhöfer Roland Seiler-Blarer Lars Dyrskjøt Kent Mouw